Close
Achema middle east
swop processing & packaging

content

Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint,...

REGEN-COV Antibody Cocktail Is Active Against SARS-CoV-2 Variants First Identified in the UK and South Africa

Regeneron Pharmaceuticals, Inc. announced that researchers in Dr. David Ho's Columbia University lab and Regeneron scientists have independently confirmed that REGEN-COVTM (casirivimab and imdevimab...

COVID-19 Vaccine AstraZeneca authorised for use in the EU

AstraZeneca’s COVID-19 vaccine has been granted a conditional marketing authorisation (CMA) in the EU for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in...

Novartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine

Novartis announced that it has signed an initial agreement to leverage its manufacturing capacity and capabilities in order to address the COVID-19 pandemic by...

Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research

Lonza has expanded its renowned human primary cell offerings with the launch of fully customizable, high-quality cryopreserved Leukopaks. The frozen Leukopaks will enable long-distance...

Exothera expands range of state-of-the-art technologies by acquiring the NevoLine Upstream platform for Belgium site

Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO) delivering customized process development and GMP (Good Manufacturing Practices) manufacturing services for gene therapy...

The Pistoia Alliance Launches Its Enhanced President’s Startup Challenge

The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life science and healthcare R&D, has launched its revised...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »